Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ART-6043 by Artios Pharma for Prostate Cancer: Likelihood of Approval
ART-6043 is under clinical development by Artios Pharma and currently in Phase II for Prostate Cancer. According to GlobalData, Phase...
ART-6043 by Artios Pharma for Solid Tumor: Likelihood of Approval
ART-6043 is under clinical development by Artios Pharma and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
ART-6043 by Artios Pharma for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
ART-6043 is under clinical development by Artios Pharma and currently in Phase II for Human Epidermal Growth Factor Receptor 2...
ART-0380 by Artios Pharma for Anal Cancer: Likelihood of Approval
ART-0380 is under clinical development by Artios Pharma and currently in Phase II for Anal Cancer. According to GlobalData, Phase...
ART-0380 by Artios Pharma for Endometrial Cancer: Likelihood of Approval
ART-0380 is under clinical development by Artios Pharma and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...